How common is AML in children?

Which treatments are given in the hospital and which are given in a clinic?
(Guest Lecture): January 2023 - Financial Preparing for Your 2022 Tax Filing
Is fertility a discussion most AML specialists would have with patients?
(Guest Lecture) Mezigdomide (CC-92480) | Paul Richardson, MD | ASH 2022
Individualized Prediction Model in Myeloma & Genome Sequencing | Francesco Maura, MD | ASH 2022
MODAKAFUSP ALFA (TAK-573) | Dan Vogl, MD, MSCE | ASH 2022
Opioid Use in Managing Pain in Myeloma | Karen Sweiss, PharmD | ASH 2022
Frailty and Multiple Myeloma | Hira Mian, MD, MSc | ASH 2022
MajesTEC-2 Trial | Emma Searle, MBChB MA MRCP FRCPath PhD | ASH 2022
Barriers to Participation in Hematology Trials | Shakira Grant, MBBS & Jiona Mills | ASH 2022
How to Better Diagnose Patients With High-Risk Myeloma | Martin Kaiser, MD | ASH 2022
The Need for New Clinical Trial Strategies | Hearn J. Cho, MD | ASH 2022
Advancements in Immunotherapy Agents | Hearn J. Cho, MD | ASH 2022